Fawaz E Alanazi

10PUBLICATIONS
43CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 27, 2026
Antiviral Drugs in HIV and Cardiovascular Disease: Mechanistic Insights and Clinical Implications.

Helal F Hetta, Fawaz E Alanazi, Hanan Alshareef

|Dec 31, 2025
Broad-Spectrum RAS Inhibition in Pancreatic Ductal Adenocarcinoma: Mechanistic Advances and Therapeutic Promise.

Fawaz E Alanazi, Yasser Alatawi, Abdullah Alattar

|Nov 27, 2025
Therapeutic Impact of Zanubrutinib in Chronic Lymphocytic Leukemia: Evidence from a Systematic Review and Single-Arm Meta-Analysis.

Yasser Alatawi, Fawaz E Alanazi, Abdullah Alattar

|Nov 27, 2025
Evaluating the Safety and Efficacy of PD-1 Inhibitors in HIV Patients Diagnosed with Lung Cancer: A Systematic Review.

Helal F Hetta, Yasser Alatawi, Fawaz E Alanazi

|Sep 27, 2025
Recent Advances in the Development of Pro-PROTAC for Selective Protein Degradation.

Fady Hakem, Ahmad Abdelwaly, Reem Alshaman

|Jul 30, 2025
Is Anlotinib and Radiotherapy Combination Effective for Non-Small-Cell Lung Cancer with Brain Metastases? A Systematic Scoping Review and Meta-Analysis.

Helal F Hetta, Mostafa A Sayed Ali, Saleh F Alqifari

Pageof 2